Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-24

Clinical Trial Update: Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c [NA]

View source ↗

Summary

This document reports a clinical trial evaluating Viome's Precision Nutrition Program to reduce HbA1c in individuals with diabetes or prediabetes, currently in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Viome | Conditions: Diabetes, Pre Diabetes | NA | Status: RECRUITING